Brought to you by 
Third Rock Ventures leads Lotus Tissue Repair's Series A round
28 Jul 2011
Executive Summary
Third Rock Ventures was the sole investor in newly formed dermatology/wound healing therapeutics company Lotus Tissue Repair Inc.’s $2.75mm Series A venture round. The VC firm will also contribute one board member. According to the start-up's Form D filing, it may bring in another $23.75mm before closing the financing.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Third Rock Ventures leads Lotus Tissue Repair's Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice